ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sesen Bio Enters Mfg. and Supply Partnership with Qilu Pharma
December 10, 2020Sesen Bio has entered into a commercial manufacturing and supply framework agreement—CMO Agreement—with the company's partner in China, Qilu Pharmaceutical. -
Sesen Bio Reports Positive, Preliminary Data Update from Trial for Bladder Cancer
August 12, 2019Sesen Bio reported updated, preliminary primary and secondary endpoint data from the Company’s Phase 3 VISTA trial further supporting the strong benefit-risk profile of Vicinium for the potential treatment of ... -
Sesen Bio Announces Successful Pre-BLA Meeting with FDA for Vicinium®
June 13, 2019Sesen Bio has completed a successful Type B Pre-Biologics License Application (BLA) meeting regarding the approval path for Vicinium for the treatment of patients with high-risk, Bacillus Calmette-Guérin (BCG) unresponsive, non-muscle invasive bladder can
Pharma Sources Insight January 2025
